KIN
Kindred Biosciences, Inc.
KIN
KIN
Delisted
KIN was delisted on the 27th of August, 2021.
77 hedge funds and large institutions have $113M invested in Kindred Biosciences, Inc. in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 27 increasing their positions, 24 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
77
Holding in Top 10
–
Calls
$325K
Puts
–
Top Buyers
| 1 | +$1.14M | |
| 2 | +$717K | |
| 3 | +$651K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$395K |
| 5 |
Morgan Stanley
New York
|
+$354K |
Top Sellers
| 1 | -$404K | |
| 2 | -$359K | |
| 3 | -$328K | |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$241K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$191K |